Your browser doesn't support javascript.
loading
Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network.
Ardissino, Gianluigi; Salardi, Stefania; Colombo, Elisa; Testa, Sara; Borsa-Ghiringhelli, Nicolò; Paglialonga, Fabio; Paracchini, Valentina; Tel, Francesca; Possenti, Ilaria; Belingheri, Mirco; Civitillo, Cristina Felice; Sardini, Stefano; Ceruti, Rossella; Baldioli, Carlo; Tommasi, Paola; Parola, Luciana; Russo, Fiorella; Tedeschi, Silvana.
Affiliation
  • Ardissino G; Center for Prevention, Control and Management of Hemolytic Uremic Syndrome, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy. ardissino@italkid.org.
  • Salardi S; Center for Prevention, Control and Management of Hemolytic Uremic Syndrome, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Colombo E; Center for Prevention, Control and Management of Hemolytic Uremic Syndrome, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Testa S; Center for Prevention, Control and Management of Hemolytic Uremic Syndrome, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Borsa-Ghiringhelli N; Center for Prevention, Control and Management of Hemolytic Uremic Syndrome, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Paglialonga F; Center for Prevention, Control and Management of Hemolytic Uremic Syndrome, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Paracchini V; Center for Prevention, Control and Management of Hemolytic Uremic Syndrome, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Tel F; Center for Prevention, Control and Management of Hemolytic Uremic Syndrome, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Possenti I; Center for Prevention, Control and Management of Hemolytic Uremic Syndrome, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Belingheri M; Center for Prevention, Control and Management of Hemolytic Uremic Syndrome, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Civitillo CF; Center for Prevention, Control and Management of Hemolytic Uremic Syndrome, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Sardini S; Azienda Ospedaliera Carlo Poma, Mantova, Italy.
  • Ceruti R; Azienda Ospedaliera Carlo Poma, Mantova, Italy.
  • Baldioli C; Ospedale di Cittiglio, Cittiglio, Italy.
  • Tommasi P; V. Buzzi Children's Hospital, Milan, Italy.
  • Parola L; Ospedale Fornaroli, Magenta, Italy.
  • Russo F; Azienda Ospedaliera, Desio e Vimercate, Vimercate, Italy.
  • Tedeschi S; Center for Prevention, Control and Management of Hemolytic Uremic Syndrome, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
Eur J Pediatr ; 175(4): 465-73, 2016 Apr.
Article in En | MEDLINE | ID: mdl-26498648
ABSTRACT
UNLABELLED Despite the severity of HUS and the fact that it represents a leading cause of acute kidney injury in children, the general epidemiology of HUS is all but well documented. The present study provides updated, population-based, purely epidemiological information on HUS in childhood from a large and densely populated area of northern Italy (9.6 million inhabitants, 1.6 million children). We systematically reviewed the files concerning patients with STEC-HUS and atypical HUS (aHUS) over a 10-year observation period (January 2003-December 2012). We included all incident cases with a documented first episode of HUS before the age of 18 years. We identified 101 cases of HUS during the 10 years. The overall mean annual incidence was 6.3 cases/million children aged <18 years (range 1.9-11.9), and 15.7/million of age-related population (MARP) among subjects aged <5 years; aHUS accounted for 11.9 % of the cases (mean incidence 0.75/MARP). The overall case fatality rate was 4.0 % (3.4 % STEC-HUS, 8.3 % aHUS).

CONCLUSION:

Given the public health impact of HUS, this study provides recent, population-based epidemiological data useful for healthcare planning and particularly for estimating the financial burden that healthcare providers might have to face in treating HUS, whose incidence rate seems to increase in Northern Italy. WHAT IS KNOWN • HUS is a rare disease, but it represents the leading cause of acute kidney injury in children worldwide. • STEC-HUS (also called typical, D + HUS) is more common compared to atypical HUS, but recent, population-based epidemiological data (incidence) are scanty. What is New • Comprehensive, population-based epidemiological data concerning both typical and atypical HUS based on a long observational period.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Escherichia coli / Escherichia coli Infections / Hemolytic-Uremic Syndrome Type of study: Incidence_studies / Prognostic_studies / Screening_studies Limits: Adolescent / Child / Child, preschool / Humans / Infant Country/Region as subject: Europa Language: En Journal: Eur J Pediatr Year: 2016 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Escherichia coli / Escherichia coli Infections / Hemolytic-Uremic Syndrome Type of study: Incidence_studies / Prognostic_studies / Screening_studies Limits: Adolescent / Child / Child, preschool / Humans / Infant Country/Region as subject: Europa Language: En Journal: Eur J Pediatr Year: 2016 Document type: Article Affiliation country: